Assisted reproductive technologies (ART) have become an integral component of infertility care worldwide. Alongside their widespread clinical use, growing ...

By John Vandermosten, CFA NASDAQ:LGND READ THE FULL LGND RESEARCH REPORT In the wake of the December analyst day, Ligand Pharmaceuticals, Inc.’s (NASDAQ:LGND) partners have seen meaningful activity ...

The FDA Center for Drug Evaluation and Research has accepted a letter of intent for the first biomarker for idiopathic pulmonary fibrosis into its Biomarker Qualification Program, according to a press ...

Sexual dysfunction is a reality for many women, but the subject remains taboo. A large percentage of women remain untreated, a problem that is exacerbated by the shortage of treatment options for ...

Myqorzo (aficamten) is a new therapy for oHCM, improving functional capacity and symptoms, with an annual cost of $108,400. The Myqorzo & You program provides personalized support, including insurance ...

Professor Jaewon Ko’s research team at DGIST, in collaboration with international researchers, identified that the loss of function of the MDGA2 gene induces severe developmental and epileptic encepha ...

Software developers have spent the past two years watching AI coding tools evolve from advanced autocomplete into something ...

The funding comes from the Personalized Regenerative Immunocompetent Nanotechnology Tissue (PRINT) program at ARPA-H, an agency within the U.S. Department of Health and Human Services. The PRINT ...

Orphan Drug Designation applies to approximately 50,000 Patients who predominantly suffer from severe chronic pain due ...

Renewable Natural Gas (RNG) 45Z Tax Credit Revenue -- Current guidance implies an annual run rate of $30 million, pending final regulatory guidance.

New charter program quantifies publisher authority across AI-mediated discovery and zero-click conversions to establish ...

SomaTX Design Inc. is the maker of KneeMo®, a smart wearable device designed to reduce knee pain and improve quadriceps ...